CN103998420B - (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 - Google Patents
(s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 Download PDFInfo
- Publication number
- CN103998420B CN103998420B CN201280060570.9A CN201280060570A CN103998420B CN 103998420 B CN103998420 B CN 103998420B CN 201280060570 A CN201280060570 A CN 201280060570A CN 103998420 B CN103998420 B CN 103998420B
- Authority
- CN
- China
- Prior art keywords
- pain
- neuropathic pain
- hours
- treatment
- phenylpropanamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C*(C(Cc1cc*(*)cc1)COCC(N)O)C(CCc1ccccc1)=O Chemical compound C*(C(Cc1cc*(*)cc1)COCC(N)O)C(CCc1ccccc1)=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568219P | 2011-12-08 | 2011-12-08 | |
| US61/568,219 | 2011-12-08 | ||
| PCT/IL2012/050512 WO2013084238A1 (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103998420A CN103998420A (zh) | 2014-08-20 |
| CN103998420B true CN103998420B (zh) | 2018-04-17 |
Family
ID=48573665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280060570.9A Active CN103998420B (zh) | 2011-12-08 | 2012-12-06 | (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9381173B2 (enExample) |
| EP (1) | EP2788317B1 (enExample) |
| JP (2) | JP6411893B2 (enExample) |
| CN (1) | CN103998420B (enExample) |
| AU (1) | AU2012348529B2 (enExample) |
| CA (1) | CA2856665C (enExample) |
| DK (1) | DK2788317T3 (enExample) |
| ES (1) | ES2763946T3 (enExample) |
| HU (1) | HUE048570T2 (enExample) |
| IN (1) | IN2014MN00919A (enExample) |
| WO (1) | WO2013084238A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173813A1 (en) * | 2014-05-14 | 2015-11-19 | Novaremed Ltd. | Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes |
| KR102062268B1 (ko) | 2018-05-18 | 2020-01-03 | 한국교통대학교 산학협력단 | 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제 |
| IL282718B2 (en) * | 2019-01-23 | 2024-08-01 | Novaremed Ltd | Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases |
| EP3939578A1 (en) | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
| WO2026037478A1 (en) | 2023-08-11 | 2026-02-19 | Novaremed AG | (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060148874A1 (en) * | 2004-03-26 | 2006-07-06 | Eliahu Kaplan | Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| WO2009109850A2 (en) * | 2008-03-06 | 2009-09-11 | Novaremed Ltd. | A method of treating or preventing pain |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2535975T3 (es) | 2002-10-03 | 2015-05-19 | Novaremed Ltd. | Compuestos para su uso en el tratamiento de enfermedades autoinmunitarias, enfermedades inmunoalérgicas y rechazo de trasplantes de órganos o tejidos |
| US20090197781A1 (en) | 2008-01-31 | 2009-08-06 | Hari Babu Sunkara | Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers |
| US8802734B2 (en) * | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| PL2475361T3 (pl) | 2009-09-09 | 2020-07-13 | Novaremed Ltd. | N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
-
2012
- 2012-12-06 DK DK12855522.4T patent/DK2788317T3/da active
- 2012-12-06 WO PCT/IL2012/050512 patent/WO2013084238A1/en not_active Ceased
- 2012-12-06 HU HUE12855522A patent/HUE048570T2/hu unknown
- 2012-12-06 AU AU2012348529A patent/AU2012348529B2/en active Active
- 2012-12-06 CA CA2856665A patent/CA2856665C/en active Active
- 2012-12-06 ES ES12855522T patent/ES2763946T3/es active Active
- 2012-12-06 EP EP12855522.4A patent/EP2788317B1/en active Active
- 2012-12-06 CN CN201280060570.9A patent/CN103998420B/zh active Active
- 2012-12-06 JP JP2014545450A patent/JP6411893B2/ja active Active
-
2014
- 2014-05-16 IN IN919MUN2014 patent/IN2014MN00919A/en unknown
- 2014-05-30 US US14/291,901 patent/US9381173B2/en active Active
-
2017
- 2017-07-21 JP JP2017142137A patent/JP2018021023A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060148874A1 (en) * | 2004-03-26 | 2006-07-06 | Eliahu Kaplan | Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| WO2009109850A2 (en) * | 2008-03-06 | 2009-09-11 | Novaremed Ltd. | A method of treating or preventing pain |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012348529A1 (en) | 2014-06-12 |
| JP2015500831A (ja) | 2015-01-08 |
| IN2014MN00919A (enExample) | 2015-04-17 |
| CA2856665C (en) | 2019-11-12 |
| US9381173B2 (en) | 2016-07-05 |
| US20140275270A1 (en) | 2014-09-18 |
| EP2788317B1 (en) | 2019-10-02 |
| EP2788317A1 (en) | 2014-10-15 |
| DK2788317T3 (da) | 2020-01-20 |
| JP6411893B2 (ja) | 2018-10-31 |
| CA2856665A1 (en) | 2013-06-13 |
| JP2018021023A (ja) | 2018-02-08 |
| WO2013084238A1 (en) | 2013-06-13 |
| CN103998420A (zh) | 2014-08-20 |
| AU2012348529B2 (en) | 2017-03-30 |
| HUE048570T2 (hu) | 2020-08-28 |
| EP2788317A4 (en) | 2015-07-08 |
| HK1201059A1 (en) | 2015-08-21 |
| ES2763946T3 (es) | 2020-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3693258B2 (ja) | イソブチルｇａｂａまたはその誘導体を含有する鎮静剤 | |
| JP3018135B2 (ja) | 鎮痛剤 | |
| Walker | Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: NSAID: An Update on Their Analgesic Effects | |
| CN103998420B (zh) | (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 | |
| EP3666258B1 (en) | Method of treating prader-willi syndrome | |
| AU2018383098B2 (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| JP2020075938A (ja) | 神経精神系障害の治療のための組成物および方法 | |
| EP1219624B1 (en) | Remedies for neuropathic pain and model animals of neuropathic pain | |
| CN106456637B (zh) | (s)-吡吲哚及其药学上可接受的盐的药学用途 | |
| EP1256344A1 (en) | Remedies for endothelin-induced diseases | |
| JP2019048820A (ja) | メチルナルトレキソンの経口組成物を用いたオピオイド誘導性便秘症の治療及び予防のための方法 | |
| EP2705843A1 (en) | Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesis | |
| RU2322977C1 (ru) | Синтетическое анальгетическое средство и способ лечения на основе этого средства | |
| JP2022518288A (ja) | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 | |
| HK1201059B (en) | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide | |
| CN110279691B (zh) | 一种外科术后护理镇痛药物及其用途 | |
| JP6461961B2 (ja) | ジエチル（２−シアノエチル）ホスホネートの医薬組成物および使用 | |
| CN1196932A (zh) | (+)－o－去甲基反胺苯环醇作为止痛药的口服应用 | |
| BRPI0613281A2 (pt) | combinação terapêutica contendo um bloqueador de receptor nmda e uma substáncia analgésica e narcótica | |
| CN106102726A (zh) | 4‑苄磺酰基‑2‑丁腈 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1201059 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |